Medtronic initiates post-market study of Talent thoracic stent graft
Medtronic, a medical technology company, has started Thrive1, the company’s US post-market clinical study of its Talent thoracic stent graft for the endovascular repair of thoracic aortic aneurysms.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.